Table 1 Distribution of general characteristics of included patients across all the groups.
Characteristics | All eyes | FCS + | FCS − | p value | ||
|---|---|---|---|---|---|---|
N = 113 | Vitreous adhesion group, N = 13 | Vitreous detachment group, N = 6 | Vitreous adhesion group, N = 48 | Vitreous detachment group, N = 46 | ||
Age, year (mean ± SD) | 71 ± 7 | 68 ± 8 | 71 ± 5 | 71 ± 6 | 72 ± 8 | 0.412 |
Sex (%) | ||||||
Male | 33 (29) | 4 (31) | 1 (17) | 16 (33) | 12 (26) | 0.788 |
Female | 80 (71) | 9 (69) | 5 (83) | 32 (67) | 34 (74) | |
Eye (%) | ||||||
Right | 48 (42) | 10 (77) | 3 (50) | 18 (38) | 17 (37) | 0.364 |
Left | 65 (58) | 3 (23) | 3 (50) | 30 (62) | 29 (63) | |
BCVA, logMAR (mean ± SD) | 0.08 ± 0.17 | 0.09 ± 0.10 | 0.12 ± 0.12 | 0.09 ± 0.19 | 0.06 ± 0.16 | 0.743 |
FTMH size in the fellow eye, µm (mean ± SD) | 461 ± 168 | 471 ± 229 | 546 ± 189 | 432 ± 167 | 476 ± 146 | 0.347 |
Refractive error, D (mean ± SD) | 0.61 ± 1.62 | 0.09 ± 1.51 | 0.27 ± 2.06 | 1.10 ± 1.50 | 0.29 ± 1.64 | 0.451 |
Follow up time, months (mean ± SD) | 14 ± 10 | 24 ± 17 | 15 ± 11 | 13 ± 10 | 12 ± 7 | 0.003* |
